Business Description
Avivagen Inc
NAICS : 325412
SIC : 3741
ISIN : CA05382F2026
Description
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -33.94 | |||||
| Debt-to-Equity | -0.78 | |||||
| Debt-to-EBITDA | -2.67 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -310.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.6 | |||||
| 3-Year EBITDA Growth Rate | 17.5 | |||||
| 3-Year EPS without NRI Growth Rate | 34.7 | |||||
| 3-Year FCF Growth Rate | 23.7 | |||||
| 3-Year Book Growth Rate | 5.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 92.1 | |||||
| 9-Day RSI | 85.96 | |||||
| 14-Day RSI | 81.17 | |||||
| 6-1 Month Momentum % | -31.25 | |||||
| 12-1 Month Momentum % | -86.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.03 | |||||
| Quick Ratio | 0.02 | |||||
| Days Inventory | 302.33 | |||||
| Days Sales Outstanding | 74.43 | |||||
| Days Payable | 812.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.3 | |||||
| Shareholder Yield % | 600.57 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.74 | |||||
| Operating Margin % | -228.63 | |||||
| Net Margin % | -648.05 | |||||
| FCF Margin % | -101.71 | |||||
| ROA % | -553.57 | |||||
| ROIC % | -52.49 | |||||
| ROC (Joel Greenblatt) % | -3517.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.33 | |||||
| EV-to-EBIT | -2.74 | |||||
| EV-to-EBITDA | -2.8 | |||||
| EV-to-Revenue | 10.63 | |||||
| EV-to-FCF | -10.38 | |||||
| Price-to-Median-PS-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -36.5 | |||||
| FCF Yield % | -188.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VIVXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avivagen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.526 | ||
| EPS (TTM) ($) | -0.045 | ||
| Beta | -0.03 | ||
| Volatility % | 630.01 | ||
| 14-Day RSI | 81.17 | ||
| 14-Day ATR ($) | 0.000213 | ||
| 20-Day SMA ($) | 0.00457 | ||
| 12-1 Month Momentum % | -86.91 | ||
| 52-Week Range ($) | 0.0004 - 0.0208 | ||
| Shares Outstanding (Mil) | 77.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avivagen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avivagen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avivagen Inc Frequently Asked Questions
What is Avivagen Inc(VIVXF)'s stock price today?
The current price of VIVXF is $0.01. The 52 week high of VIVXF is $0.02 and 52 week low is $0.00.
When is next earnings date of Avivagen Inc(VIVXF)?
The next earnings date of Avivagen Inc(VIVXF) is .
Does Avivagen Inc(VIVXF) pay dividends? If so, how much?
Avivagen Inc(VIVXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers